Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
---|
09/15/2004 | EP1456173A1 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines |
09/15/2004 | EP1456172A1 Pyrrolidine-2-ones as factor xa inhibitors |
09/15/2004 | EP1456171A1 Substituted cyclohexane derivatives |
09/15/2004 | EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
09/15/2004 | EP1088825B9 Enantiomerically pure substituted oxaaza compounds, salts of the same, and processes for the preparation of both |
09/15/2004 | EP0986384A4 Inhibitors of protein isoprenyl transferases |
09/15/2004 | EP0775689B9 Novel amine derivative, process for producing the same, and use thereof as antiarrhythmic |
09/15/2004 | EP0710109B1 Method for identifying a PDE IV inhibitor |
09/15/2004 | EP0693072B9 Method for the synthesis of 4- and/or 5-(di)substituted 2-aminoimidazoles from 2-aminoimidazoles and aldehydes |
09/15/2004 | CN1529593A 2-pyrrolidone derivatives as prostanoid agonists |
09/15/2004 | CN1528746A Intermediate for preparing compounds having serotonin-2 receptor antagonistic and alpha-1 blocking action and its preparing method |
09/15/2004 | CN1528745A Pyrrolidine matrix metall oprotease inhibitor and preparing method thereof |
09/15/2004 | CN1528744A Positron emitted computerized tomography imaging agent benzamide derivative synthesizing method |
09/15/2004 | CN1166699C Recovery of modifier compounds and polar organic compounds from a poly (arylene sulfide) |
09/15/2004 | CN1166654C Benzoylguanidine derivatives wit advantageous properties, method for producing them and their use in production of medicaments |
09/15/2004 | CN1166635C Trifuoro methylpyrrol carboxamides |
09/15/2004 | CN1166634C 15N-proline separating and purifying meethod |
09/15/2004 | CN1166633C New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them |
09/15/2004 | CN1166629C Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same |
09/15/2004 | CN1166614C Indandione compounds and its preparing process and application |
09/14/2004 | US6790860 Pyrrolidine derivatives |
09/14/2004 | US6790597 Rapid cure, stable to elevated temperatures, are highly flexible, have low moisture uptake |
09/14/2004 | CA2280708C Cetp activity inhibitors |
09/14/2004 | CA2103110C Insecticidal n'-substituted-n,n'-diacylhydrazines |
09/10/2004 | WO2004076416A1 Method of obtaining an antiepileptic agent |
09/10/2004 | WO2004076415A1 1- (hetero)aroyl-pyrrolidine-2-carboxylic acid derivatives useful as anti.viral agents |
09/10/2004 | WO2004076407A2 Pyrrolidine derivatives as oxytocin antagonists |
09/10/2004 | WO2004076388A2 Process for preparing 2-methylpyrrolidine and specific enantiomers thereof |
09/10/2004 | WO2004075847A2 METHODS AND COMPOUNDS FOR THE TREATMENT OF Aß ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS |
09/10/2004 | WO2004056755A3 Compounds for the inhibition of non-proteolytic enzymes |
09/10/2004 | WO2004056727A8 Process of making chalcone derivatives |
09/10/2004 | WO2004041211A3 INHIBITORS OF β-SECRETASE, AND THEIR USE FOR THE PREVENTION OR TREATMENT OF ALZHEIMER’S DISEASE OR MILD COGNITIVE IMPAIRMENT |
09/10/2004 | WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives |
09/10/2004 | WO2004007445A3 Protein kinase c modulators, and methods of use thereof |
09/10/2004 | WO2004007444A3 N-hydroxyamide derivatives possessing antibacterial activity |
09/10/2004 | WO2003079984A3 Substituted tetracycline compounds |
09/10/2004 | CA2515801A1 Process for preparing 2-methylpyrrolidine and specific enantiomers thereof |
09/09/2004 | US20040176615 Forming calcium salt from ester |
09/09/2004 | US20040176595 Glucocorticoid receptor modulators |
09/09/2004 | US20040176589 Processing a dicarbonyl compound to form cyclic compound reaction with alkylation |
09/09/2004 | US20040176462 NPY Y5 antagonist |
09/09/2004 | US20040176461 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
09/09/2004 | US20040176428 treatment of Type 2 diabetes mellitus, obesity and lipid disorders; coadministration with HMG CoA reductase inhibitors |
09/09/2004 | US20040176421 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis |
09/09/2004 | US20040176382 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease; |
09/09/2004 | US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants |
09/09/2004 | DE10307725A1 Korrosions-und Gashydratinhibitoren mit verbesserter Wasserlöslichkeit und erhöhter biologischer Abbaubarkeit Corrosion and gas hydrate inhibitors with improved water solubility and increased biodegradability |
09/09/2004 | DE10306250A1 Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted N-Arylheterozyklen, processes for their preparation and their use as medicaments |
09/08/2004 | EP1453792A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease |
09/08/2004 | EP1453790A2 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof |
09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
09/08/2004 | EP1453503A2 Ep4 receptor agonist, compositions and methods thereof |
09/08/2004 | EP1453501A1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity |
09/08/2004 | EP1289972B1 Serine protease inhibitors |
09/08/2004 | EP1289950B1 Serine protease inhibitors |
09/08/2004 | EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
09/08/2004 | EP1084119B1 Aromatic amine derivatives as pharmaceutical agents |
09/08/2004 | EP0944581A4 Process of preparing substituted acrylamides |
09/08/2004 | EP0763009B1 Photocleavable conjugates for the detection and isolation of biomolecules |
09/08/2004 | CN1527876A Compounds, compositions, and methods for controlling biofilms |
09/08/2004 | CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications |
09/07/2004 | US6787564 For treating hypoxia protective, nootropic and neurodegenerative diseases (cerbral ischemia, alzheimer's disease, and vascular dementia) |
09/07/2004 | US6787563 Antidiarrhea agents; gastrointestinal disorders |
09/07/2004 | US6787540 Compounds useful as reversible inhibitors of cysteine proteases |
09/07/2004 | US6787522 Antibacterial agents |
09/07/2004 | CA2105709C Substituted cyclohexane derivatives, processes for their preparation and the use of the compounds for treating diseases |
09/07/2004 | CA2093770C Aspartic acid derivatives, their preparation and use |
09/02/2004 | WO2004074256A1 Tetrahydroisoquinolinyl sulfamic acids |
09/02/2004 | WO2004074250A1 Novel compounds and compositions containing the same |
09/02/2004 | WO2004074238A1 Phenethylamino sulfamic acids |
09/02/2004 | WO2004073634A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
09/02/2004 | WO2004073606A2 Sulfonamide derivatives as ppar modulators |
09/02/2004 | WO2004073598A2 Solid phase synthesis of antitumoral compounds |
09/02/2004 | WO2004073585A2 Methode of manufacturing glimepiride and the respective intermediate |
09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
09/02/2004 | US20040171860 Novel acylating reagents |
09/02/2004 | US20040171848 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
09/02/2004 | US20040171845 Process for preparing 2-methylpyrrolidine and specific enantiomers thereof |
09/02/2004 | US20040171842 VIRICIDES; uSING A SECONDARY AMIDE COMPOUNDAIDS |
09/02/2004 | US20040171670 Neurological diseases and disorders; such as 3-fluoro-10,11-dihydro-5-(2-aminoethyl)-5H-dibenzo[a,d]cycloheptene |
09/02/2004 | US20040171655 Active against cancer proliferation, growth, and metastasis; such as 3,4,5-trimethoxy-n-(2-methyl-3-phenyl-allyl)-n-[2-(1-methyl-pyrrolidin-2-yl)-thyl]-benzamide; side effect reduction |
09/02/2004 | US20040171642 Neurokinin 1 (NK-1) receptor antagonists; depression, anxiety, pain, inflammation, migraine, emesis, postherpetic neuralgia |
09/02/2004 | US20040171639 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
09/02/2004 | US20040171614 Novel gamma secretase inhibitors |
09/02/2004 | US20040171608 Synthesis of clasto-lactacystin beta-lactone and analogs thereof |
09/02/2004 | US20040171520 Melanocortin receptor-specific peptidomimetics |
09/02/2004 | US20040171490 Preventing infestation of plants by phytopathogenic microorganisms; horticulture, agriculture |
09/02/2004 | US20040170890 novel 2,2,2-trifluoro-N-(trifluoromethanesulfonyl) acetamide*tetraethyl ammonium salt |
09/02/2004 | US20040170634 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
09/02/2004 | DE3844978B4 New tri:phenyl-cerium cpd. |
09/02/2004 | CA2767153A1 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
09/02/2004 | CA2515520A1 Methode of manufacturing glimepiride and the respective intermediate |
09/02/2004 | CA2515313A1 Solid phase synthesis of antitumoral compounds |
09/02/2004 | CA2512883A1 Sulfonamide derivatives as ppar modulators |
09/01/2004 | EP1453087A1 Microelectronic assembly |
09/01/2004 | EP1452534A1 Pleuromutlin derivatives as antimicrobials |
09/01/2004 | EP1452524A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses" |
09/01/2004 | EP1452522A2 Novel compounds and compositions as protease inhibitors |
09/01/2004 | EP1451195A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide |
09/01/2004 | EP1451179A1 Pyrrole synthesis |